Powered by

Vanda Pharmaceuticals Reports Third Quarter 2019 Financial Results; -- Q3 2019 Total net product sales of $59.5 million, a 21% increase year over year

Nov 06, 2019 - PR Newswire
Board and Executive Moves-Financial Results

PR Newswire

 Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq:VNDA) today announced financial and operational results for the third quarter ended September 30, 2019.

"These results affirm Vanda's corporate strategy, and continue to demonstrate our ability to grow our commercial assets and expand our pipeline of products," said Mihael H. Polymeropoulos, M.D., Vanda's President and CEO. "I am proud of the progress we have made in our research and development programs, with several new filin...